Search

everythinglearnresearchcommunity

for

Search:↓

Estrogen-progestin contraception lowers ovarian, endometrial, and colon cancer risk but may raise breast and cervical cancer risk, helps with menstrual and acne issues, and new methods are as effective as pills. Metformin helps overweight women with PCOS and insulin resistance, and dopamine agonists treat prolactinomas.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Bicalutamide may be a promising alternative treatment for female pattern hair loss.

Finasteride may help reduce symptoms in male Tourette syndrome patients.

Intralesional steroid injections are safe and effective for treating severe alopecia areata.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Platelet-rich plasma shows promise for treating various female reproductive health issues but requires more research.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Zusanli acupoint injection of metoclopramide effectively treats functional dyspepsia.

Latanoprost 0.1% may effectively treat hair loss.

Combining low-level laser therapy with scalp microneedling and a clobetasol solution significantly improves androgenetic alopecia.

Men with early-onset hair loss are less responsive to bromocriptine's heart and metabolism benefits.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

There are various effective hormone treatments for puberty induction in boys and girls with hypogonadism, and starting treatment early is important.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

Paroxetine relieves pain by increasing allopregnanolone levels.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

Trilostane effectively improved symptoms in dogs with a certain adrenal gland disorder.

Deuruxolitinib improves anxiety and depression in severe alopecia areata patients.

A new compound was effective for imaging prostate cancer in rats.

Methylprednisolone infusions can help some people with severe alopecia regrow hair.

Botulinum neurotoxin injections into the pelvic muscles successfully prevented priapism relapse for over six months.

Optimal long-acting finasteride injection dose found: 16.8 mg, effective for one month.

Bicalutamide, a drug with a good safety profile, is a promising new treatment for female pattern hair loss.